Home
 /
Papers
 /
Bioinformatics
 /
Learning transcriptome architecture from sequence with a long-context RNA foundation model
Preprint
Open access
V1
Top 1% · Validated by QED

Learning transcriptome architecture from sequence with a long-context RNA foundation model

Ali Saberi, Benedict Choi, Shaopu Zhou +11 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2024.08.26.609813
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Bioinformatics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Mach-1 establishes that transcriptome architecture—isoform abundance, splicing, and variant effects—is predictable zero-shot from pre-mRNA sequence alone, converting a decades-old genomic challenge into a deployable framework for RNA engineering and clinical variant interpretation.

QED claims analysis

Summary

Mach-1, a long-context RNA foundation model trained on a comprehensive compendium of full-length transcriptome data from 26 cancer cell lines, learns the sequence grammar governing transcriptome architecture through splice-aware tokenization and StripedHyena architecture, enabling accurate zero-shot prediction of isoform abundance, splicing patterns, and variant effects, while also generating biologically realistic and functionally viable synthetic transcripts that recapitulate human transcriptome structure.

See full analysis
Main Claim 1 –

C2L2 Long-Read Compendium Captures Tissue-Specific Full-Length Isoforms

Supporting evidence

  • C2L2 Tissue-Specific Isoform Programs Explain Over 80% Variance
Main Claim 2 –

Mach-1 StripedHyena Enables 64K Splice-Aware Causal RNA Modeling

Main Claim 3 –

Mach-1 Learns Splicing Grammar from Splice Sites and Motifs

Supporting evidence

  • RBP Knockdowns Confirm Mach-1-Predicted Splicing Regulation
  • Mach-1 Discovers Cis-Regulatory Motifs Including SRSF1 and PCBP2
  • PAS Embedding Clusters Reveal Polyadenylation Motif Regulation
Main Claim 4 –

Mach-1 Zero-Shot Predicts Abundance, Exon Trapping, and Variant Effects

Supporting evidence

  • Mach-1 Predicts Exon-Trapping Inclusion in Out-of-Distribution Sequences
  • Mach-1 Outperforms Tools for Noncoding Variant Pathogenicity Prediction
  • CRISPR Validates Mach-1 Splice-Altering Variants Missed by SpliceAI
  • Mach-1 Predicts Somatic Mutation Effects on Splicing and Expression
  • Mach-1 Embeddings Predict Cell Line-Specific Cis- and Trans-Regulation

Abstract

Linking DNA sequence to genomic function remains one of the grand challenges in genetics and genomics. Here, we present a large-scale compendium of single-molecule transcriptome sequencing of diverse cancer cell lines, revealing their isoform diversity and specificity. We used this compendium to build Mach-1, an RNA foundation model that learns how the nucleotide sequence of unspliced pre-mRNA dictates transcriptome architecture—the relative abundances and molecular structures of mRNA isoforms. By using the Striped-Hyena architecture, Mach-1 handles extremely long sequence inputs at nucleotide resolution (64 kilobase pairs), allowing for quantitative, zero-shot prediction of all aspects of transcriptome architecture, spanning isoform abundance, structure, and variant-induced splicing changes. To test both the interpretive and generative capabilities of Mach-1, we experimentally validated its learned regulatory grammar and predictions through perturbation of RNA-binding proteins nominated by Mach-1 to impact targeted splicing, precise CRISPR editing of variants of uncertain significance that the model predicted to alter splicing, and de novo transcript synthesis and expression in human cells. Together, this release establishes a new foundation for sequence-to-transcript modeling. Mach-1’s representations can be extended and fine-tuned across a spectrum of biological contexts, from variant interpretation to RNA engineering.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?